Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Legend Biotech Corp ADR
(NQ:
LEGN
)
58.60
-0.33 (-0.56%)
Streaming Delayed Price
Updated: 10:28 AM EDT, Jul 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Legend Biotech Corp ADR
< Previous
1
2
3
4
5
6
7
8
Next >
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
November 02, 2022
Upgrades
Via
Benzinga
Carnival, Amazon, Iamgold And Other Big Gainers From Tuesday
October 19, 2022
U.S. stocks closed higher on Monday, with the Dow Jones gaining more than 300 points. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Legend Biotech's Shares Jumped 14.2% On Tuesday
October 18, 2022
The company presented news regarding early revenue figures for a multiple myeloma therapy it collaborated on.
Via
The Motley Fool
Short Volatility Alert: Legend Biotech Corporation
June 24, 2022
On Thursday, shares of Legend Biotech Corporation (NASDAQ: LEGN) experienced volatile short activity. After the activity, the stock price went up +6.97% to $51.10. The...
Via
Benzinga
Legend Biotech Shares Move Higher After Bullish BMO Pitch
June 17, 2022
Via
Benzinga
Short Volatility Alert: Legend Biotech Corporation
June 17, 2022
On Thursday, shares of Legend Biotech Corporation (NASDAQ: LEGN) experienced volatile short activity. After the activity, the stock price went down -1.38% to $42.96. The...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
Upgrades
Via
Benzinga
Mainz Biomed (MYNZ) nominates two notable leaders in key areas of the diagnostics field to its Board of Directors
September 29, 2022
Via
AB Newswire
Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday
October 19, 2022
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares jumped 170.1% to close at $0.1194 on Tuesday after gaining 4% on Monday.
Via
Benzinga
CARVYKTI™ (ciltacabtagene autoleucel) Receives Approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
September 27, 2022
From
Legend Biotech Corporation
Via
Business Wire
Legend Biotech to Host 2022 R&D Day on Monday, October 3, 2022
September 15, 2022
From
Legend Biotech Legend Biotech Corporation
Via
Business Wire
No Early Relief for JW Therapeutics from Cancer Wonder Drug
September 07, 2022
Key Takeaways: JW Therapeutics prices its new cancer therapy at around a million yuan, with the high production costs hard to bring down. Large-scale market expansion is not going to be easy The...
Via
Benzinga
Legend Biotech Stock Joins Elite Club Of Stocks With RS Ratings Over 90
September 01, 2022
On Thursday, Legend Biotech stock had its Relative Strength (RS) Rating upgraded to 91, up from 87 a day earlier.
Via
Investor's Business Daily
Legend Biotech Announces Participation in Upcoming Investor Conferences
August 19, 2022
From
Legend Biotech
Via
Business Wire
NexImmune Pauses Developing Multiple Myeloma Hopeful, Citing Competition
August 16, 2022
NexImmune Inc (NASDAQ: NEXI) cited the competitive environment in the blood cancer space as the reason for
Via
Benzinga
Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2022
August 05, 2022
From
Legend Biotech Corporation
Via
Business Wire
Legend Biotech Appoints Three New Directors and Elects New Chairman of the Board
August 04, 2022
From
Legend Biotech
Via
Business Wire
Week In Review: China Biopharma Tops $2.8 Billion In Week's Dealmaking
July 30, 2022
CSPC Pharma out-licensed global rights for its antibody drug conjugate targeting Claudin18.2 to Elevation Oncology of New York City. CSPC will receive a $27 million upfront payment and up to $148...
Via
Talk Markets
PayPal, Alphabet And Some Other Big Stocks Recording Gains On Wednesday
July 28, 2022
U.S. stocks closed sharply higher on Wednesday, with the Dow Jones jumping more than 400 points. Here is the list of some big stocks moving higher in the previous session.
Via
Benzinga
Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy
July 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Walmart, Shopify And Some Other Big Stocks Recording Losses On Tuesday
July 27, 2022
U.S. stocks closed lower on Monday, with the Nasdaq Composite dropping more than 200 points. Here is the list of some big stocks moving lower in the previous session.
Via
Benzinga
Legend Biotech Corporation Announces Pricing of Public Offering
July 26, 2022
From
Legend Biotech Corporation
Via
Business Wire
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
July 26, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
July 25, 2022
Gainers
Via
Benzinga
Legend Biotech Corporation Announces Proposed Public Offering
July 25, 2022
From
Legend Biotech Corporation
Via
Business Wire
How Newcomer Arcellx Is Looking To Rival Johnson & Johnson In Cancer
June 06, 2022
This biotech stock launched in February to work on CAR-T treatments.
Via
Investor's Business Daily
Longer-Term Data from CARTITUDE Program Continue to Show Deep and Durable Responses with Ciltacabtagene Autoleucel Across Lines of Therapy in Patients with Multiple Myeloma
June 04, 2022
From
Legend Biotech
Via
Business Wire
Legend Biotech Announces U.S. FDA Clearance of IND Application for Solid Tumor CAR-T, LB1908 for Relapsed or Refractory Gastric, Esophageal and Pancreatic Cancers
June 03, 2022
From
Legend Biotech
Via
Business Wire
Legend Biotech Reports First Quarter 2022 Financial Results and Recent Highlights
June 01, 2022
From
Legend Biotech
Via
Business Wire
Legend Biotech to Host Investors at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
May 31, 2022
From
Legend Biotech
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.